The proportion of immune subsets expressing Cxcl9 and/or Cxcl10 in the spleen, as well as the pancreatic draining lymph node (dLN) and tumor were assessed using the gating strategy in Fig. 5B–C. Here, CXCL10 is linked to neoplasm.